Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Urges Regulatory Changes To Pull EU Market From Doldrums

This article was originally published in The Tan Sheet

Executive Summary

The time appears right for Rx-to-OTC switches as European Union members struggle to control expanding health budgets in the face of aging populations and the continuing global economic crisis.
Advertisement

Related Content

Oxytrol, Flomax Switches Show Gap Between U.S., U.K. Pathways
Oxytrol, Flomax Switches Show Gap Between U.S., U.K. Pathways
GlaxoSmithKline's OTC Garage Sale Includes alli, FiberChoice
People In Brief
EU Centralized Switch Process Needs Longer Exclusivity, More Trust - Execs
EU Centralized Switch Process Needs Longer Exclusivity, More Trust - Execs
EU-Wide OTC Approvals Highlight The Drawbacks Of National Processes

Topics

Advertisement
UsernamePublicRestriction

Register

PS105150

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel